|
|||||
|
|
| TICL矫治高度近视并散光的临床研究 | |
| 引用本文： | 杨浩江,司马晶,李林,窦晓燕,吕秀芳,魏玉丽. TICL矫治高度近视并散光的临床研究[J]. 国际眼科杂志, 2013, 13(5): 980-983 |
| 作者姓名： | 杨浩江 司马晶 李林 窦晓燕 吕秀芳 魏玉丽 |
| 作者单位： | 中国广东省深圳市第二人民医院眼科;中国广东省深圳市第二人民医院眼科;中国广东省深圳市第二人民医院眼科;中国广东省深圳市第二人民医院眼科;中国广东省深圳市儿童医院眼科;中国广东省深圳市第二人民医院眼科 |
| 基金项目： | 深圳市科技计划项目(No.201103107) |
| 摘 要： | 目的:探讨散光矫正型植入性眼内接触镜(TICL)矫治高度近视并散光的安全性、有效性、稳定性。方法:高度近视并散光的患者15例30眼接受散光矫正型眼内接触镜植入术,观察术后1,3,6,12mo时裸眼视力、矫正远视力、屈光状态、眼压、角膜内皮细胞计数及并发症情况等。结果:术后裸眼视力均有明显提高,术后12mo裸眼视力达到1.0以上的有27眼(90%),等效球镜±0.5D以内28眼(93%)。术后无1例矫正远视力下降1行或1行以上。术后1mo与术后12mo相比,30眼(100%)等效球镜变化均在0.5D之内。手术前后角膜内皮细胞计数比较无显著性差异(P=0.31)。术后12mo未见并发性白内障、继发性青光眼等并发症。结论:散光矫正型植入性眼内接触镜(TICL)矫治高度近视并散光安全、有效。 |
| 关 键 词： | 人工晶状体 高度近视 散光 |
| 收稿时间： | 2013-02-28 |
| 修稿时间： | 2013-04-28 |
Clinical research on toric implantable collamer lens for patients with high myopic astigmatism |
|
| Hao-Jiang Yang,Jing Sima,Lin Li,Xiao-Yan Dou,Xiu-Fang Lü,Yu-Li Wei. Clinical research on toric implantable collamer lens for patients with high myopic astigmatism[J]. International Eye Science, 2013, 13(5): 980-983 | |
| Authors: | Hao-Jiang Yang Jing Sima Lin Li Xiao-Yan Dou Xiu-Fang Lü Yu-Li Wei |
| Affiliation: | Department of Ophthalmology, the Second People's Hospital of Shenzhen, Shenzhen 518000, Guangdong Province, China;Department of Ophthalmology, the Second People's Hospital of Shenzhen, Shenzhen 518000, Guangdong Province, China;Department of Ophthalmology, the Second People's Hospital of Shenzhen, Shenzhen 518000, Guangdong Province, China;Department of Ophthalmology, the Second People's Hospital of Shenzhen, Shenzhen 518000, Guangdong Province, China;Department of Ophthalmology, Shenzhen Children's Hospital, Shenzhen 518000, Guangdong Province, China;Department of Ophthalmology, the Second People's Hospital of Shenzhen, Shenzhen 518000, Guangdong Province, China |
| Abstract: | AIM: To evaluate the efficacy, safety and stability of toric implantable collamer lens(TICL)for patients with high myopic astigmatism. METHODS: Totally 15 patients(30 eyes)undergoing TICL placement were included. The uncorrected visual acuity(UCVA), corrected distance visual acuity(CDVA), refraction,intraocular pressure, endothelial cell counts and complications were regularly observed on 1 month, 3, 6 and 12 months post-operation. RESULTS: All eyes had a significant increase in UCVA. 12 months after surgery, 27 eyes(90%)achieved UCVA better than 1.0. 28 eyes(93%)had a spherical equivalent(SE)within ±0.5D. None lost one or more lines of CDVA. 30 eyes changed within ±0.5D when comparing 1 month and 12 months. Postoperative endothelial cell density did not show a significant difference from preoperative measurements(P=0.31). Complications were not found after surgery. CONCLUSION: TICL appears to be safe and effective for correction of high myopic astigmatism. |
| Keywords: | intraocular lens high myopia astigmatism |
| 本文献已被 CNKI 等数据库收录！ | |
| 点击此处可从《国际眼科杂志》浏览原始摘要信息 | |
| 点击此处可从《国际眼科杂志》下载全文 | |